Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer

Detalles Bibliográficos
Autor principal: Rizzo, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151130/
https://www.ncbi.nlm.nih.gov/pubmed/37005558
http://dx.doi.org/10.1111/1759-7714.14877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151130/
https://www.ncbi.nlm.nih.gov/pubmed/37005558
http://dx.doi.org/10.1111/1759-7714.14877

Ejemplares similares